Change of Control Agreements in the Health Care Equipment & Supplies Industry
518 Contracts & Agreements
- Abbott Laboratories (4 contracts)
- ABIOMED Inc (5)
- ACCURAY INC (1)
- Adams Respiratory Therapeutics, Inc. (1)
- ADNEXUS THERAPEUTICS, INC. (5)
- Alphatec Holdings, Inc. (1)
- Angiodynamics Inc (10)
- Apollo Endosurgery, Inc. (1)
- AtriCure, Inc. (1)
- ATRION CORP (4)
- Avinger Inc (11)
- Baxter International Inc. (5)
- Bayhill Therapeutics, Inc. (2)
- BIOLASE, INC (4)
- Boston Scientific (2)
- Cantel Medical Corporation (3)
- CERUS CORP (4)
- CHF Solutions, Inc. (2)
- Co-Diagnostics, Inc. (1)
- Colfax CORP (2)
- CONMED Corporation (7)
- Coronado Topco, Inc. (1)
- CryoLife, Inc. (19)
- Cutera, Inc. (15)
- CV THERAPEUTICS INC (1)
- Dare Bioscience, Inc. (2)
- DEXCOM INC (5)
- DYNATRONICS CORP (1)
- Edwards Lifesciences (2)
- Envista Holdings Corp (1)
- GLAUKOS Corp (9)
- Haemonetics (7)
- Hill-Rom Holdings Inc. (10)
- Hologic (39)
- HYPERION THERAPEUTICS INC (1)
- Integer Holdings Corporation (4)
- Integra Lifesciences Holdings (9)
- Invacare Corporation (7)
- iRhythm Technologies, Inc. (4)
- IRIDEX CORP (10)
- Juno Therapeutics, Inc. (1)
- KEWAUNEE SCIENTIFIC CORP (34)
- MABVAX THERAPEUTICS HOLDINGS, INC. (1)
- Medtronic plc (2)
- MELINTA THERAPEUTICS, INC. (11)
- Meridian Bioscience, Inc. (2)
- MESA LABORATORIES INC (1)
- MINERVA SURGICAL INC (1)
- MYOMO INC (1)
- NEVRO CORP (19)
- Ocera Therapeutics, Inc. (3)
- OraSure Technologies, Inc. (1)
- Orthofix Medical Inc. (24)
- Outset Medical, Inc. (6)
- Peloton Therapeutics, Inc. (1)
- PRO DEX INC (3)
- PROCEPT BioRobotics Corp (4)
- Pulmonx Corp (1)
- QUIDEL CORP (16)
- Quotient Ltd (12)
- Ra Medical Systems, Inc. (8)
- ReShape Lifesciences Inc. (1)
- RxSight, Inc. (4)
- Sandbridge Acquisition Corp (1)
- SI-BONE, Inc. (3)
- Silk Road Medical Inc (9)
- Sintx Technologies, Inc. (2)
- SmileDirectClub, Inc. (2)
- STAAR SURGICAL CO (2)
- STRATA Skin Sciences, Inc. (2)
- Structure Therapeutics Inc. (1)
- Surmodics, Inc. (9)
- Talis Biomedical Corp (2)
- Talon Therapeutics, Inc. (2)
- Teleflex Inc (26)
- The Cooper Companies (10)
- TREACE MEDICAL CONCEPTS, INC. (11)
- Trillium Therapeutics Inc. (1)
- Varex Imaging Corporation (2)
- Varian Medical Systems (20)
- West Pharmaceutical Services (5)
- Zimmer Biomet Holdings (26)
- ZimVie Inc. (2)
- Form of Executive Change in Control Agreement between the Company and certain officers (STAAR SURGICAL CO, Filed With SEC on February 27, 2024)
- Change of Control Severance Agreement, dated November 10, 2023, by and between Artivion, Inc. and Lance A. Berry (CryoLife, Inc., Filed With SEC on February 23, 2024)
- Form of Change in Control Severance Agreement with Mark Bezjak (Zimmer Biomet Holdings, Filed With SEC on February 23, 2024)
- Amendment to Change in Control Severance Agreement dated February 19, 2024 between Zimmer GmbH and Wilfred van Zuilen (Zimmer Biomet Holdings, Filed With SEC on February 23, 2024)
- Form of Amendment to Change in Control Severance Agreement with Ivan Tornos, Suketu Upadhyay, Rachel Ellingson, Lori Winkler and Paul Stellato (Zimmer Biomet Holdings, Filed With SEC on February 23, 2024)
- Executive Change in Control and Severance Policy as Amended (iRhythm Technologies, Inc., Filed With SEC on February 22, 2024)
- Amended and Restated Change in Control and Severance Agreement by and between Myomo, Inc. and Harry Kovelman dated February 21, 2024 (MYOMO INC, Filed With SEC on February 22, 2024)
- Form of Amended and Restated Change in Control and Severance Agreement for non-Chief Executive Officer executive officers (Outset Medical, Inc., Filed With SEC on February 21, 2024)
- Form of Amended and Restated Change in Control and Severance Agreement for Chief Executive Officer (Outset Medical, Inc., Filed With SEC on February 21, 2024)
- Form of Change of Control Agreement between Integer Holdings Corporation and its Ireland-based executive officers (for agreements entered into after January 19, 2022) (Integer Holdings Corporation, Filed With SEC on February 20, 2024)
- Form of Change of Control Agreement between Integer Holdings Corporation and its U.S.-based executive officers (for agreements entered into after January 19, 2022) (Integer Holdings Corporation, Filed With SEC on February 20, 2024)
- Change in Control and Severance Agreement, dated as of January 15, 2024, between Orthofix Medical Inc. and Julie Andrews (Orthofix Medical Inc., Filed With SEC on January 17, 2024)
- Change in Control and Severance Agreement, dated as of January 8, 2024, between Orthofix Medical Inc. and Massimo Calafiore (Orthofix Medical Inc., Filed With SEC on January 9, 2024)
- Change in Control Agreement dated as of December 21, 2023 by and between Atrion Corporation and Cindy Ferguson (ATRION CORP, Filed With SEC on December 28, 2023)
- Form of Severance and Change in Control Agreement (Coronado Topco, Inc., Filed With SEC on December 1, 2023)
- Change in Control and Severance Agreement, dated June 21, 2023, between Orthofix Medical Inc. and Puja Leekha (Orthofix Medical Inc., Filed With SEC on November 8, 2023)
- Change in Control and Severance Agreement, dated October 2, 2023, between Orthofix Medical Inc. and Geoffrey Gillespie (Orthofix Medical Inc., Filed With SEC on November 8, 2023)
- Change in Control and Severance Agreement effective as of November 2, 2023 between Silk Road Medical, Inc. and Charles McKhann (Silk Road Medical Inc, Filed With SEC on November 2, 2023)
- Change in Control Severance Agreement, dated as of August 21, 2023, by and between Zimmer Biomet Holdings, Inc. and Ivan Tornos (Zimmer Biomet Holdings, Filed With SEC on August 22, 2023)
- Owlet, Inc. Executive Change in Control Severance Plan (Sandbridge Acquisition Corp, Filed With SEC on August 14, 2023)
- Change in Control Agreement, dated August 9, 2023 by and between Biolase, Inc. and Steven Sandor (BIOLASE, INC, Filed With SEC on August 10, 2023)
- Change in Control Agreement, dated August 9, 2023 by and between Biolase, Inc. and Jennifer Bright (BIOLASE, INC, Filed With SEC on August 10, 2023)
- Amended and Restated Change in Control and Severance Agreement effective as of June 22, 2022 between Silk Road Medical, Inc. and Andrew Davis (Silk Road Medical Inc, Filed With SEC on August 8, 2023)
- Amended and Restated Change in Control and Severance Agreement effective as of June 22, 2022 between Silk Road Medical, Inc. and Lucas Buchanan (Silk Road Medical Inc, Filed With SEC on August 8, 2023)
- Amended and Restated Change in Control and Severance Agreement effective as of June 22, 2022 between Silk Road Medical, Inc. and Erica Rogers (Silk Road Medical Inc, Filed With SEC on August 8, 2023)
- Severance and Change of Control Agreement dated (Hologic, Filed With SEC on August 1, 2023)
- Severance and Change of Control Agreement dated (Hologic, Filed With SEC on August 1, 2023)
- Severance and Change of Control Agreement dated (Hologic, Filed With SEC on August 1, 2023)
- Change in Control Severance Agreement, dated June 20, 2023, between Greg Siller and the Company (NEVRO CORP, Filed With SEC on August 1, 2023)
- Amendment No. 1 to Change in Control Severance Agreement, dated as of April 19, 2023, by and between Kashif Rashid and the Company (NEVRO CORP, Filed With SEC on August 1, 2023)
- Amendment No. 1 to Change in Control Severance Agreement, dated as of April 19, 2023, by and between Niamh Pellegrini and the Company (NEVRO CORP, Filed With SEC on August 1, 2023)
- Amendment No. 1 to Change in Control Severance Agreement, dated as of April 19, 2023, by and between Rod MacLeod and the Company (NEVRO CORP, Filed With SEC on August 1, 2023)
- Change in Control Agreement between Baxter International Inc. and Christopher Toth, dated as of June 15, 2023 (Baxter International Inc., Filed With SEC on July 27, 2023)
- Change of Control Severance Agreement, entered into June 23, 2023, between Invacare Holdings Corporation and Kai Zhu (Invacare Corporation, Filed With SEC on June 26, 2023)
- Change in Control and Severance Agreement, dated June 19, 2023, between the Company and Patrick L. Keran (Orthofix Medical Inc., Filed With SEC on June 21, 2023)
- Change in Control and Severance Agreement, date June 19, 2023, between the Company and Kevin Kenny (Orthofix Medical Inc., Filed With SEC on June 21, 2023)
- Change in Control and Severance Agreement, date June 19, 2023, between the Company and Kimberley A. Elting (Orthofix Medical Inc., Filed With SEC on June 21, 2023)
- Change in Control and Severance Agreement, dated June 19, 2023, between the Company and John J. Bostjancic (Orthofix Medical Inc., Filed With SEC on June 21, 2023)
- Change in Control and Severance Agreement, dated June 19, 2023, between the Company and Keith C. Valentine (Orthofix Medical Inc., Filed With SEC on June 21, 2023)
- DexCom, Inc. Amended and Restated Severance and Change in Control Plan effective June 1, 2017, and as amended on May 18, 2023 (DEXCOM INC, Filed With SEC on May 19, 2023)
